How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
PVP in Pharmaceutical Applications Market
- By Application: Drug Delivery Systems, Tablet Coatings, Binder in Tablets, Suspending Agent in Liquid Formulations, Film Forming Agent
- By Formulation Type: Oral Solid Dosage Forms, Topical Formulations, Injectable Formulations, Ophthalmic Preparations, Inhalation Products
- By Molecular Weight Grade: Low Molecular Weight PVP, Medium Molecular Weight PVP, High Molecular Weight PVP
- By End-Use Industry: Pharmaceutical Companies, Contract Research Organizations (CROs), Biotechnology Firms, Generic Drug Manufacturers
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Drug Delivery Systems leads By Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 7 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 255 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.165 →
- 11 Company Profiles 7 players: SWOT & benchmarking p.173 →
Full report · locked preview
Everything inside the PVP in Pharmaceutical Applications Market report
A complete, evidence-based study - 11 chapters and 107 sections covering market size, segmentation across 4 axes, regional analysis and 7 company profiles, forecast to 2033.
Segmentation covered
Application 5
Formulation Type 5
Molecular Weight Grade 3
End-Use Industry 4
Companies profiled
BASF SE
Ashland Global Holdings Inc.
Jungbunzlauer Suisse AG
LyondellBasell Industries N.V.
Kao Corporation
BASF Corporation
Ashland Inc.
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
7 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Ashland Global Holdings Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Jungbunzlauer Suisse AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →LyondellBasell Industries N.V.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.173 →Kao Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.178 →BASF Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Ashland Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.191 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,757M by 2033 · 6.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Drug Delivery Systems53.6
- Tablet Coatings7.4
- Binder in Tablets8.5
- Suspending Agent in Liquid Formulations14.2
- Film Forming Agent16.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$532.8M → $979.7M · 7.9%
Europe$371.3M → $599.0M · 6.2%
Asia Pacific$339.0M → $591.1M · 7.2%
Latin America$209.9M → $393.7M · 8.2%
Middle East and Africa$161.4M → $265.5M · 6.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.872026
6.892027
6.892028
6.912029
6.922030
6.922031
6.942032
6.952033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- BASF SE20.5
- Ashland Global Holdings Inc.22.4
- Jungbunzlauer Suisse AG5.3
- LyondellBasell Industries N.V.5.0
- Kao Corporation12.2
- BASF Corporation6.5
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Application25.7%
Formulation Type39.5%
Molecular Weight Grade15.8%
End-Use Industry19.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.6
- Europe21.2
- Asia Pacific20.9
- Latin America13.9
- Middle East and Africa9.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
7 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| BASF SE | 97 | 86 | 89 | 76 | 88 | 79 | 86 |
| Ashland Global Holdings Inc. | 85 | 70 | 85 | 86 | 88 | 73 | 81 |
| Jungbunzlauer Suisse AG | 68 | 82 | 72 | 72 | 88 | 73 | 76 |
| LyondellBasell Industries N.V. | 63 | 67 | 61 | 67 | 74 | 58 | 65 |
| Kao Corporation | 73 | 69 | 76 | 72 | 52 | 64 | 68 |
| BASF Corporation | 62 | 70 | 50 | 62 | 53 | 67 | 61 |
| Ashland Inc. | 64 | 44 | 53 | 52 | 62 | 54 | 55 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- BASF SE
- Ashland Global Holdings Inc.
- Jungbunzlauer Suisse AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| BASF SE | ✓ | ✓ | ✓ | ✓ | ◐ | ✓ |
| Ashland Global Holdings Inc. | ✓ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Jungbunzlauer Suisse AG | ◐ | ✓ | ◐ | ◐ | ✓ | ◐ |
| LyondellBasell Industries N.V. | ✓ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Kao Corporation | ◐ | ◐ | ◐ | ✓ | − | − |
| BASF Corporation | ◐ | − | − | ◐ | − | ◐ |
| Ashland Inc. | ◐ | ◐ | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1BASF SE86
2Ashland Global Holdings Inc.81
3Jungbunzlauer Suisse AG76
4Kao Corporation68
5LyondellBasell Industries N.V.65
6BASF Corporation61
7Ashland Inc.55
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
BASF SEAshland Global Holdings Inc.
Challenger2
Strong scale, closing on the leaders.
Jungbunzlauer Suisse AGKao Corporation
Contender2
Focused players with pockets of strength.
LyondellBasell Industries N.V.BASF Corporation
Niche1
Specialists in a single segment or region.
Ashland Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Application in North America, then scale across PVP in Pharmaceutical Applications Market — a $446M beachhead inside a $7.67B market.
Beachhead (SOM)$446Mobtainable near-term
Serviceable (SAM)$2.90Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Drug Delivery Systems
Best fit — highest urgency & budget in Application.
Economic buyer79 fit
Tablet Coatings
Strong fit — clear ROI and a fast path to value.
End user65 fit
Binder in Tablets
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Formulation Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Molecular Weight Grade
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales41%
Partner / channel31%
Digital / self-serve20%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win PVP in Pharmaceutical Applications Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified25%
Evaluation14%
Closed-won7%
$14.5KCAC
$59KLTV
4.0:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
PVP in Pharmaceutical Applications Market is a resilient opportunity — $4.88B by 2033, compounding at 3.7%.
TAM · 2025$3.66Btoday
TAM · 2033$4.88Bforecast
CAGR3.7%2027–2033
Cumulative$38.2Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.88BTotal addressable market
SAM$1.70BServiceable available market
SOM$365MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →3.7% CAGR
Demand compounds through 2033, outpacing GDP across Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application moving from early to mainstream — durable secular demand.
Consolidation upside
7+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.88BLarge & growingTAM by 2033 at 3.7% CAGR
$1.70BServiceable nowreachable with today’s model
$365MBeachhead winobtainable near-term share
7+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.80BBear2.4% CAGR
$4.88BBase3.7% CAGR
$6.24BBull4.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Formulation Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
PVP in Pharmaceutical Applications Market — a $5.67B market by 2033. Plan: grow share from 5.9% to 13.0%.
Market size · 2033$5.67Btotal addressable
Market CAGR6.3%2027–2033
Target share13.0%from 5.9% today
Revenue ambition$737Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.9% | 13.0% | At risk |
| Revenue | $350M | $737M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 36.8% | 40.9% | At risk |
| Customer retention | 87.7% | 95.7% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Formulation Type capability
A defensible second engine — invest in Formulation Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Formulation Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $98M capacity & capability investment
- Greenlight bolt-on M&A in Formulation Type
- Authorise North America expansion plan
- Fund R&D program for Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossBehind
- Input-cost & supply riskBehind
- Regulatory / policy changeOn track
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the PVP in Pharmaceutical Applications Market conversation — a $3.48B market you can size, segment and defend in minutes.
Market size · 2033$3.48Btotal opportunity
Growth5.9%CAGR to 2033
Addressable buyers947+accounts in scope
Typical ROI7.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application
Goal Grow share in Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.4×return on cost, year one
< 2 mopayback period
$88K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
7+players profiled in this market
Coverage includes
BASF SEAshland Global Holdings Inc.Jungbunzlauer Suisse AGLyondellBasell Industries N.V.Kao CorporationBASF CorporationAshland Inc.
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your PVP in Pharmaceutical Applications Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
PVP in Pharmaceutical Applications Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →High Spectrometer Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportSafety Prefilled Syringes Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportMulti-Component Crystal Force Sensor Market
Market size, share, segmentation and regional forecast.
$981M market · 2025 base year
View reportDental Washing Machine Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportSertraline Hydrochloride Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportGuanosine Hydrate Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportL-Tryptophan Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportParticle Size Analysis Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportToric Contact Lenses Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportNebulizers, Inhalers And Respirators For Asthma Treatment Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportNorditropin Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportSmart Clothing Sensor Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.